The digital health M&A wave is continuing, this time with Universal Health Services’ plan to acquire virtual behavioral health company Talkspace for $835 million. And it’s a deal that makes a lot of sense for both parties, experts say. According to one healthcare expert, this is a strategic move for both companies. For UHS, the […]
Why UHS Is Acquiring Talkspace for $835M Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Why UHS Is Acquiring Talkspace for $835M Read More »
Universal Health Services, Inc. (NYSE: UHS) announces that it has entered into a definitive agreement to acquire Talkspace, Inc. (NASDAQ: TALK) for $5.25 per share. The enterprise value for the transaction is approximately $835 million, which UHS intends to finance with borrowings pursuant to its existing revolving credit facility. Talkspace is a leading virtual behavioral
Universal Health Services, Inc. to Acquire Talkspace, Inc. Read More »
You are unauthorized to view this page.
Universal Health Services, Inc. to Acquire Talkspace, Inc. Read More »
Quantum Health, the leading healthcare navigation company, announces it has acquired CirrusMD, a premier on-demand virtual care company. The acquisition brings together navigation and physician-led virtual care to drive more immediate care integration and stronger outcomes for members across their healthcare journey. This acquisition builds on Quantum Health’s recent momentum expanding clinically-validated provider steerage through
QC Capital Group, a diversified alternative investment firm focused on scalable, high-impact platforms, announced its strategic investment in My Pediatric Doctor, a next-generation 24/7 urgent care pediatric telemedicine company designed to deliver high-quality healthcare for children from the comfort of their own homes. My Pediatric Doctor is the first and only fully Nationwide 24/7 Urgent
You are unauthorized to view this page.
Hims & Hers is making a major global expansion with its planned acquisition of Australian digital health company Eucalyptus, a good move for the company as it faces regulatory and legal challenges in the U.S. over its sale of compounded GLP-1s, experts say. This is a smart deal for Hims & Hers, according to Michael
What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus Read More »
You are unauthorized to view this page.
What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus Read More »
